Talkspace (TALK) Competitors $2.98 -0.03 (-1.00%) (As of 12/20/2024 05:30 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TALK vs. WGS, USPH, PNTG, INNV, DCGO, EUDA, PIII, KDLY, VSEE, and ATPCShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include GeneDx (WGS), U.S. Physical Therapy (USPH), The Pennant Group (PNTG), InnovAge (INNV), DocGo (DCGO), EUDA Health (EUDA), P3 Health Partners (PIII), Kindly MD (KDLY), Vsee Health (VSEE), and Agape ATP (ATPC). These companies are all part of the "health services" industry. Talkspace vs. GeneDx U.S. Physical Therapy The Pennant Group InnovAge DocGo EUDA Health P3 Health Partners Kindly MD Vsee Health Agape ATP GeneDx (NASDAQ:WGS) and Talkspace (NASDAQ:TALK) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, community ranking, analyst recommendations, profitability and risk. Which has higher earnings & valuation, WGS or TALK? Talkspace has lower revenue, but higher earnings than GeneDx. Talkspace is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeneDx$267.23M7.96-$175.77M-$3.11-24.89Talkspace$181.29M2.78-$19.18M-$0.01-298.00 Do analysts prefer WGS or TALK? GeneDx presently has a consensus target price of $59.33, indicating a potential downside of 23.34%. Talkspace has a consensus target price of $4.38, indicating a potential upside of 46.81%. Given Talkspace's stronger consensus rating and higher probable upside, analysts plainly believe Talkspace is more favorable than GeneDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeneDx 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Talkspace 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in WGS or TALK? 61.7% of GeneDx shares are owned by institutional investors. Comparatively, 57.4% of Talkspace shares are owned by institutional investors. 27.3% of GeneDx shares are owned by insiders. Comparatively, 21.7% of Talkspace shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more volatility & risk, WGS or TALK? GeneDx has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Does the MarketBeat Community believe in WGS or TALK? GeneDx received 5 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 47.62% of users gave GeneDx an outperform vote while only 41.67% of users gave Talkspace an outperform vote. CompanyUnderperformOutperformGeneDxOutperform Votes1047.62% Underperform Votes1152.38% TalkspaceOutperform Votes541.67% Underperform Votes758.33% Is WGS or TALK more profitable? Talkspace has a net margin of -0.76% compared to GeneDx's net margin of -31.25%. Talkspace's return on equity of -1.17% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets GeneDx-31.25% -13.35% -6.91% Talkspace -0.76%-1.17%-0.99% Does the media favor WGS or TALK? In the previous week, GeneDx had 9 more articles in the media than Talkspace. MarketBeat recorded 10 mentions for GeneDx and 1 mentions for Talkspace. Talkspace's average media sentiment score of 0.57 beat GeneDx's score of 0.51 indicating that Talkspace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeneDx 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Talkspace 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGeneDx beats Talkspace on 10 of the 19 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$503.39M$867.07M$5.12B$9.07BDividend YieldN/A1.90%4.91%4.22%P/E Ratio-298.0032.2091.3417.19Price / Sales2.783.751,117.70116.80Price / CashN/A25.1442.6437.86Price / Book4.202.924.794.78Net Income-$19.18M-$5.79M$120.07M$225.60M7 Day Performance-8.59%-4.93%-1.90%-1.23%1 Month Performance-9.97%-4.89%11.45%3.37%1 Year Performance20.65%226.77%30.63%16.58% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace3.2313 of 5 stars$2.98-1.0%$4.38+46.8%+24.2%$503.39M$181.29M-298.00472WGSGeneDx1.2555 of 5 stars$78.14+3.6%$59.33-24.1%+2,935.3%$2.15B$267.23M-24.251,200Insider TradeGap DownUSPHU.S. Physical Therapy3.9754 of 5 stars$97.70+4.5%$114.00+16.7%-1.8%$1.48B$604.80M99.436,720Positive NewsGap UpPNTGThe Pennant Group4.5659 of 5 stars$29.83+2.5%$38.25+28.2%+100.7%$1.02B$544.89M42.815,791Analyst ForecastNews CoveragePositive NewsINNVInnovAge1.289 of 5 stars$4.48+0.9%$6.50+45.1%-25.4%$606.84M$786.51M-37.002,350Analyst ForecastNews CoverageDCGODocGo2.5881 of 5 stars$4.44+3.5%$6.10+37.4%-15.2%$453.11M$694.97M15.324,164EUDAEUDA Health0.3178 of 5 stars$5.35-10.2%N/A+246.2%$131.76M$3.81M0.002PIIIP3 Health Partners2.3874 of 5 stars$0.19-7.3%$2.38+1,150.0%-83.0%$68.18M$1.48B-0.24500News CoverageKDLYKindly MDN/A$1.23-5.4%N/AN/A$7.35M$2.88M0.00N/AGap DownVSEEVsee HealthN/A$1.39-6.7%N/AN/A$5.01M$6.38M0.00N/ANews CoverageATPCAgape ATPN/A$1.24-13.3%N/A-88.5%$4.95M$1.35M-1.9640Positive NewsGap Down Related Companies and Tools Related Companies GeneDx Competitors U.S. Physical Therapy Competitors The Pennant Group Competitors InnovAge Competitors DocGo Competitors EUDA Health Competitors P3 Health Partners Competitors Kindly MD Competitors Vsee Health Competitors Agape ATP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TALK) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
